The Effects of An Addition of Water Enema to PEG for Colon Preparation

September 4, 2017 updated by: Somchai Leelakusolvong, Mahidol University

The Effects of An Addition of Water Enema to PEG for Colon Preparation: A Randomized Controlled Trial

The purpose of this study is to compare the preparation quality by using Ottawa Bowel Preparation Scale between the standard PEG preparation and the addition of water enema in participants scheduled for CRC screening

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Background : Good bowel preparation improves the rate of polyp detection and the time of caecal intubation during colorectal cancer (CRC) screening.

Suboptimal bowel preparation can results in adenoma miss rate up to 42% (95% CI, 35-49) and advanced adenoma miss rate up to 27% (95% CI, 17-41) The European Society of Gastrointestinal Endoscopy (ESGE) Guideline recommends a split regimen of 4L of polyethylene glycol (PEG) solution (or a same-day regimen in the case of afternoon colonoscopy) for a routine bowel preparation and the delay between the last dose of bowel preparation and colonoscopy should be minimized and no longer than 4 hours.

The investigators hypothesize that the addition of water enema to the standard PEG bowel preparation could provide the better quality of bowel preparation and then result in improvement in the rate of adenoma detection among participants scheduled for CRC screening with preparation to procedure interval > 8 hr.

The purpose of this study is to compare the preparation quality using Ottawa Bowel Preparation Scale between the standard PEG preparation and the addition of water enema in participants scheduled for CRC screening. The secondary aim is to compare the effect of the standard PEG bowel preparation and the addition of water enema in terms of adenoma detection rate, the completeness of the examination, total and withdrawal time, safety and adverse events among those scheduled for CRC screening.

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients scheduled for CRC screening
  • Bowel preparation using 3 liters of PEG solution
  • Colonoscopy performed at 8-16 hours after bowel preparation

Exclusion Criteria:

  • History of a failed bowel preparation
  • Previous colonic surgery
  • Uncontrolled underlying disease
  • Pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: DIAGNOSTIC
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
PLACEBO_COMPARATOR: No enema group

Consecutive participants will be randomly assigned to take a preparation regimen of 3 liter of PEG 8-16 hr. before colonoscopy without water enema.

Before the procedure, investigators record baseline parameters. Colonoscopies underwent by experienced endoscopists and by GI fellows. During the colonoscopy, the investigators recorded video, cecal intubation and withdraw time, amount and position of polyps, rate of complete examination and complication. The video was sent to other 2 endoscopists who did not known which participant was enema to evaluate the quality of bowel cleansing by using Ottawa bowel preparation scale and Likert scale for evaluation of side effect, complication during PEG ingestion, enema and colonoscopy, and participant satisfactory.

Addition of water enema in standard PEG preparation in participants scheduled for CRC screening.
ACTIVE_COMPARATOR: Water enema group

Consecutive participants will be randomly assigned to take a preparation regimen of 3 liter of PEG 8-16 hr. before colonoscopy and enema with sterile water until stool was clear or patient felt discomfort but not exceed 3 liter, before colonoscopy.

Before the procedure, investigators record baseline parameters. Colonoscopies underwent by experienced endoscopists and by GI fellows. During the colonoscopy, the investigators recorded video, cecal intubation and withdraw time, amount and position of polyps, rate of complete examination and complication.The video was sent to other 2 endoscopists who did not known which participant was enema to evaluate the quality of bowel cleansing by using Ottawa bowel preparation scale and Likert scale.

Addition of water enema in standard PEG preparation in participants scheduled for CRC screening.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bowel preparation quality using Ottawa Bowel Preparation Scale
Time Frame: 1 days
Evaluate Ottawa Bowel Preparation Scale by 2 endoscopists using video record
1 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The effect of addition of water enema in standard PEG bowel preparation in terms of adenoma detection rate
Time Frame: 1 days
Evaluate the adenoma detection rate compare between two groups
1 days
The effect of addition of water enema in the standard PEG bowel preparation in terms of the completeness of the examination
Time Frame: 1 day
Evaluate the completeness of examination compare between two groups
1 day
The effect of addition of water enema in the standard PEG bowel preparation in terms of total and withdrawal times
Time Frame: 1 day
Evaluate total and withdrawal times of colonoscopy procedures compare between two groups
1 day
The effect of addition of water enema in the standard PEG bowel preparation in terms of safety and adverse events
Time Frame: 3 days
Evaluate the safety and efficacy of procedures compare between two groups
3 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Somchai Leelakusolvong, M.D., Mahidol University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2013

Primary Completion (ACTUAL)

March 1, 2015

Study Completion (ACTUAL)

March 1, 2015

Study Registration Dates

First Submitted

May 3, 2017

First Submitted That Met QC Criteria

August 31, 2017

First Posted (ACTUAL)

September 1, 2017

Study Record Updates

Last Update Posted (ACTUAL)

September 7, 2017

Last Update Submitted That Met QC Criteria

September 4, 2017

Last Verified

August 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Adenoma, Bile Duct

Clinical Trials on Water enema

Subscribe